'ITP Australia & New Zealand launched in 2015 with the mission to provide people living with ITP up to date and relevant information'.
We would like to thank ITP Australia and New Zealand for joining ClinTrial Refer as our newest supporter.
ClinTrial Refer supporters play a vital role in raising awareness about ClinTrial Refer as a resource to connect to current clinical trials.
Immune Thrombocytopenia or Idiopathic Thrombocytopenia Purpura, otherwise known as ITP, is an autoimmune disease where the body doesn’t produce enough or attacks existing platelets, resulting in a low platelet count. Platelets are important to forming clots and slow bleeding.
ITP Australia and New Zealand launched in 2015 with the mission to provide people living with ITP with up-to-date and relevant information. Since then, they have been able to bring ITP patients together through in-person and virtual meetings, advocate and deliver improved access to existing and emerging therapies, showcase the available clinical trials and, most importantly, provide much-needed support for people living with ITP. This has been achieved through a growing network of stakeholders, which includes patients, industry, government and healthcare professionals.
Learn more about ITP Australia and New Zealand today and visit their website – ITPAustralia.org.au
